22nd Century Share Holder Equity 2011-2024 | XXII
22nd Century share holder equity from 2011 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
22nd Century Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$-8 |
| 2022 |
$96 |
| 2021 |
$66 |
| 2020 |
$44 |
| 2019 |
$62 |
| 2018 |
$71 |
| 2017 |
$75 |
| 2016 |
$24 |
| 2015 |
$12 |
| 2014 |
$15 |
| 2013 |
$8 |
| 2012 |
$-6 |
| 2011 |
$-1 |
| 2010 |
$-2 |
22nd Century Quarterly Share Holder Equity
(Millions of US $) |
| 2024-09-30 |
$3 |
| 2024-06-30 |
$-1 |
| 2024-03-31 |
$-12 |
| 2023-12-31 |
$-8 |
| 2023-09-30 |
$14 |
| 2023-06-30 |
$73 |
| 2023-03-31 |
$81 |
| 2022-12-31 |
$96 |
| 2022-09-30 |
$121 |
| 2022-06-30 |
$99 |
| 2022-03-31 |
$58 |
| 2021-12-31 |
$66 |
| 2021-09-30 |
$79 |
| 2021-06-30 |
$87 |
| 2021-03-31 |
$52 |
| 2020-12-31 |
$44 |
| 2020-09-30 |
$50 |
| 2020-06-30 |
$54 |
| 2020-03-31 |
$58 |
| 2019-12-31 |
$62 |
| 2019-09-30 |
$55 |
| 2019-06-30 |
$62 |
| 2019-03-31 |
$70 |
| 2018-12-31 |
$71 |
| 2018-09-30 |
$79 |
| 2018-06-30 |
$73 |
| 2018-03-31 |
$78 |
| 2017-12-31 |
$75 |
| 2017-09-30 |
$28 |
| 2017-06-30 |
$25 |
| 2017-03-31 |
$22 |
| 2016-12-31 |
$24 |
| 2016-09-30 |
$16 |
| 2016-06-30 |
$14 |
| 2016-03-31 |
$17 |
| 2015-12-31 |
$12 |
| 2015-09-30 |
$14 |
| 2015-06-30 |
$17 |
| 2015-03-31 |
$12 |
| 2014-12-31 |
$15 |
| 2014-09-30 |
$20 |
| 2014-06-30 |
$9 |
| 2014-03-31 |
$10 |
| 2013-12-31 |
$8 |
| 2013-09-30 |
$-17 |
| 2013-06-30 |
$-7 |
| 2013-03-31 |
$-8 |
| 2012-12-31 |
$-6 |
| 2012-09-30 |
$-2 |
| 2012-06-30 |
$-2 |
| 2012-03-31 |
$-3 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-3 |
| 2011-06-30 |
$-3 |
| 2011-03-31 |
$-2 |
| 2010-12-31 |
$-2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.004B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
